MedTrace Logo

Meropenem Plasma Concentration Measurements at the Pediatric Medical Ward, Oslo University Hospital, Rikshospitalet

NCT01289249 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2014-11-06

No results posted yet for this study

Summary

The object of the study is to investigate whether all included patients receive treatment that is effective against all bacteria that are defined as sensitive to meropenem with the current treatment regimen. Will the investigators findings motivate routine monitoring of plasma concentrations in children receiving meropenem? Up to 50 patients will be included in the study, and all participants are children.

Conditions

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Odd Brørs, Dr Med · Oslo University Hospital

  • Margrete L Burns, BMed · Oslo univeristy hospital

  • Øystein Riise, PhD · Oslo University Hospital

  • Tore Abrahamsen, Dr Med · Oslo univeristy hospital

  • Gaut Gadeholt, Dr Med · Oslo University Hospital

Eligibility

Min Age
3 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01289249 on ClinicalTrials.gov